MedPath

Autologous Epidermal Cell Treat for Nonhealing Postoperative Wound

Not Applicable
Recruiting
Conditions
Healing Wound
Interventions
Procedure: control treatment
Procedure: cell treatment
Registration Number
NCT06173908
Lead Sponsor
First Affiliated Hospital, Sun Yat-Sen University
Brief Summary

Postoperative incision healing (Postoperative incision non - ranging) occurred in the surgical incision more than 2 weeks after the operation is still not healing wounds.

At present, direct suture, autologous skin graft transplantation, conventional dressing change and negative pressure wound therapy are still the first-line treatment options for postoperative wound nonunion. However, the wound healing time is long and the wound healing rate is low. Autologous epidermal basal cell suspension is derived from the basal layer of the epidermis and contains 1-10% epidermal stem cells. Therefore, we plan to carry out a multi-center, prospective randomized controlled clinical trial, aiming to verify whether this technique can promote wound healing.

Detailed Description

Postoperative incision healing (Postoperative incision non - ranging) occurred in the surgical incision more than 2 weeks after the operation is still not healing wounds, show the incision infection, effusion, hemorrhage, empyema, skin lesions and skin defect. It has a high morbidity and the treatment cycle is long, the social and economic burden is heavy.

At present, direct suture, autologous skin graft transplantation, conventional dressing change and negative pressure wound therapy are still the first-line treatment options for postoperative wound nonunion. However, the wound healing time is long and the wound healing rate is low. Therefore, how to improve the wound healing rate is an urgent problem to be solved. The present study indicated that the disturbance of wound microenvironment was the main reason for the wound healing. Autologous epidermal basal cell suspension is derived from the basal layer of the epidermis and contains 1-10% epidermal stem cells. Therefore, we plan to carry out a multi-center, prospective randomized controlled clinical trial, aiming to verify whether this technique can promote wound healing.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
120
Inclusion Criteria
  • (1) the age of the subject on the day of signing the informed consent is 18 years old or above;

    (2) the diagnosis was non-union of incision, and the diagnosis criteria of non-union of incision were as follows: non-union of incision > for 2 weeks after various surgeries;

    (3) patients with stable vital signs, who are proved to be tolerable to surgery by routine examination;

    (4) the patient is in good mental state, can follow the doctor's advice and return to the hospital regularly;

    (5) understand and willing to participate in this clinical trial and provide the signed informed consent

Exclusion Criteria
  • (1) local wound complicated with malignant tumor;

    (2) during the screening period, patients showed immunosuppression due to potential diseases, long-term immunosuppressive therapy or the use of large doses of glucocorticoid (i.e.

    (3) patients with mental diseases;

    (4) patients with serious uncontrolled diseases or acute systemic infections and other serious visceral diseases such as heart, lung and brain diseases;

    (5) if the researcher considers the inclusion inappropriate;

    (6) the patients were pregnant women, fertile women who did not take appropriate contraceptive measures, lactating women during the screening period or women who planned to become pregnant within 1 month after the end of the study;

    (7) the patient participated in this study at any time in the past and the patient is participating in other clinical trials.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
control treatmentcontrol treatmentConventional method were used to treat postoperative nonhealing wounds
cell treatmentcell treatmentAutologous epidermal basal cells were used to treat postoperative nonhealing wounds
Primary Outcome Measures
NameTimeMethod
healing ratepostoperative day 7, 14, 21, 28

wound healing rate

Secondary Outcome Measures
NameTimeMethod
healing timewhen the wound was complete healed,through study completion, an average of 1 or 2 weeks

wound healing time

recurrence ratepostoperative month 3

recurrence rate

Wound reduction ratepostoperative day 7, 14, 21, 28

Wound reduction rate

Trial Locations

Locations (1)

Jiayuan Zhu

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath